New Zealand markets open in 3 hours 54 minutes
  • NZX 50

    11,090.03
    +130.58 (+1.19%)
     
  • NZD/USD

    0.5722
    -0.0003 (-0.05%)
     
  • ALL ORDS

    6,905.30
    +248.90 (+3.74%)
     
  • OIL

    86.23
    +2.60 (+3.11%)
     
  • GOLD

    1,733.00
    +31.00 (+1.82%)
     

Demand for Global Gene Therapy Market Size Will Rise at +20.10% CAGR by 2028, Value Will Cross US$ 7247.58 Million - Industry Trends, Share, Growth, Value, Analysis & Forecast Report by Facts & Factors

·9-min read
Facts & Factors
Facts & Factors

[220+ Pages Report]According to Facts and Factors, the demand analysis of Global Gene Therapy Market size & share revenue is estimated to grow about USD 7247.58 million by 2028, at a CAGR of approximately 20.10% between 2022 and 2028. The key market players are listed in the report with their sales, revenues and strategies are Novartis AG, Gilead Sciences., Shanghai Sunway Biotech Co. Ltd., Adaptimmune Therapeutics plc., Orchard Therapeutics., Bristol-Myers Squibb., Amgen Inc., Adverum Biotechnologies Inc., Jazz Pharmaceuticals, Shenzhen SiBiono GeneTech, and others.

NEW YORK, United States, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Gene Therapy Market Size, Share, Growth Analysis Report By Vector Type (Viral Vector and Non-Viral Vector), By Therapy (In Vivo Therapy and Ex Vivo Therapy), By Gene Type (Antigen, Cytokine, Tumour Suppressor, Suicide, Deficiency, Growth Factors, Receptors, and Others), By Application (Oncological Disorders, Rare Diseases, Neurological Disorders, and Other Diseases), and By Region - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecast 2022 – 2028” in its research database.

“According to the latest research study, the demand of global Gene Therapy Market size & share was valued at approximately USD 2415.10 million in 2021. The market is expected to grow above a CAGR of 20.10% and is anticipated to reach over USD 7247.58 million by 2028.”

The report analyses the Gene Therapy market’s drivers and restraints, as well as the impact they have on-demand throughout the projection period. In addition, the report examines global opportunities in the global Gene Therapy market.

What is Gene Therapy? How big is the Gene Therapy Industry?

  • Market Overview:

A gene is a basic genetic building block of life that carries a set of instructions for carrying out a certain task. The treatment for cancer, chronic illnesses, infectious diseases, and blood issues is gene therapy. In order to treat or stop the progression of a disease, gene therapy involves replacing defective genes with healthy ones within the body of the patient. The increase in chronic diseases such as cancer, rare illnesses, genetic disorders, and others is a significant driver driving the Gene Therapy Market Growth.

Get a Free Sample PDF of this Research Report for more Insights with Table of Content, Research Methodology, and Graphs - https://www.fnfresearch.com/sample/gene-therapy-market

 (A free sample of this report is available upon request; please contact us for more information.)

Our Free Sample Report Consists of the Following:

  • Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.

  • The COVID-19 Pandemic Outbreak Impact Analysis is included in the package

  • About 220+ Pages Research Report (Including Recent Research)

  • Provide detailed chapter-by-chapter guidance on Request

  • Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022

  • Includes Tables and figures have been updated

  • The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, Revenue Analysis, SWOT Analysis, Industry Major Players, Historical and Forecast Growth, Porter's 5 Forces Analysis

  • Facts and Factors research methodology

Key Insights from Primary Research

  • As per the analysis, the Gene Therapy market is likely to grow above a CAGR of around 20.10% between 2022 and 2028.

  • The Gene Therapy market size was worth around US$ 2415.10 million in 2021 and is estimated to hit approximately US$ 7247.58 million by 2028. Due to a variety of driving factors, the market is predicted to rise at a significant rate.

  • Based on Vector Type, the the viral vector segment will dominate the market in 2021. The category for viral vectors dominated the market.

  • Based on application, the oncological disorder segment will dominate the market in 2021. Factors driving the segment growth include the rising prevalence of cancer disorders.

  • On the basis of region, the “North America” will likely overtake the global market due to rising prevalence of spinal problems.

Market Dynamics

One of the main factors propelling the growth of the gene therapy market is the rise in the prevalence of chronic diseases including cancer, uncommon illnesses, genetic disorders, and others. The number of cases of uncommon diseases in the world has increased significantly, fuelling the necessity for cell and gene therapy. Owing to the rise in demand for Gene Therapy, the global Gene Therapy market is estimated to grow at a CAGR of 20.10% during the forecast period.

The increasing occurrence of uncommon illnesses has also increased competition for novel treatments, propelling the gene therapy industry. Ex-vivo gene therapy is gaining popularity for neurological therapies, which will boost gene therapy market growth. The expanding usage of gene manipulation in biotechnology applications, as well as the rising use of genome engineering in a number of treatments, is also projected to guide the gene therapy industry in the next years. High gene therapy prices and a lack of uniformity are predicted to stymie the worldwide gene therapy sector.

Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/gene-therapy-market

Gene Therapy Market: COVID-19 Impact Analysis

The COVID-19 pandemic is anticipated to benefit the industry for gene therapy. The creation of COVID-19 vaccines is expected to make substantial use of gene and cell therapy technology. Given that it comes in a single dose and can be stored at room temperature, the vaccine currently being developed is likely to be much more practical than the ones now available on the market.

The therapies of coronavirus from the perspective of RNA interference-based gene therapy also offer a more straightforward approach to combating viral genes and are likely to have a promising future, according to a January 2021 article published under the title, Emerging Patent Landscape for Gene Therapy as a Potential Cure for COVID-19.

Competitive Players

The report contains qualitative and quantitative research on the global gene therapy market, as well as detailed insights and development strategies employed by the leading competitors. The report also provides an in-depth analysis of the market's main competitors, as well as information on their competitiveness. The research also identifies and analyses important business strategies used by these main market players, such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts. The study examines, among other things, each company's global presence, competitors, service offers, and standards.

Some of the main players in the global Gene Therapy market include;

  • Novartis AG

  • Gilead Sciences.

  • Shanghai Sunway Biotech Co. Ltd.

  • Adaptimmune Therapeutics plc.

  • Orchard Therapeutics.

  • Bristol-Myers Squibb.

  • Amgen Inc.

  • Adverum Biotechnologies Inc.

  • Jazz Pharmaceuticals

  • Shenzhen SiBionoGenentech

  • Abeona Therapeutics Inc.

  • Applied Genetic Technologies Corporation

  • Intellia Therapeutics Inc.

  • REGENXBIO Inc.

Browse the full “Gene Therapy Market Size, Share, Growth Analysis Report - Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data and Forecast 2022 – 2028” Report at https://www.fnfresearch.com/gene-therapy-market

Gene Therapy Market: Segmentation Analysis

The Global Gene Therapy Market is segregated based on vector type, therapy, gene type, application, and region. Based on vector type, the market is divided into Viral Vectors and Non-Viral Vectors. Among these, the viral vector segment dominates the market in 2021. Based on therapy, the market is divided into In Vivo Therapy and Ex Vivo Therapy. Over the forecast period, the in vivo therapy segment is expected to develop at the fastest rate in 2021.

Based on gene type, the market is divided into Antigen, Cytokine, Tumour Suppressor, Suicide, Deficiency, Growth factors, Receptors and Others. Among these, the antigen segment dominates the market in 2021. Based on application, the market is divided into Oncological Disorders, Rare Diseases, Neurological Disorders and Other Diseases. Among these, the oncological disorder segment dominates the market in 2021.

Regional Analysis:

North America is expected to dominate the Global Gene Therapy Market in 2021. Several government authorities are investing in the region due to the presence of a big number of biopharma businesses and a solid regulatory environment for stimulating the growth of cellular treatment. As a result, the regional market is advancing. The existence of gene therapy research and development centers and institutions is projected to propel the market in North America.

Over the forecast period, the Asia Pacific regional market is expected to grow at a significant rate in 2021. The rising emphasis on healthcare in India is likely to fuel gene therapy demand throughout the predicted period. A rise in cancer cases in the country is also promoting the use of gene therapy in oncology therapies.

Have Any Query? Ask Our Experts: https://www.fnfresearch.com/inquiry/gene-therapy-market

Recent Industry Developments:

  • In October 2021, the National Institutes of Health, the Food and Drug Administration, ten pharmaceutical companies, and five non-profit groups launched a collaboration to speed up the discovery of gene therapy for the 30 million Americans who suffer from a rare disease. Such activities are anticipated to increase the demand for gene therapy.

  • In February 2021, BioMarin Pharmaceutical Inc. provided an update on its investigational gene therapy programs that are currently in clinical development. The Food and Drug Administration (FDA) submitted additional requests to the Company for information needed to remedy the clinical hold issued in September 2021 for the PHEARLESS Phase 1/2 trial of BMN 307.

Key questions answered in this report:

  • What is the market size and growth rate forecast for Gene Therapy industry?

  • What are the main driving factors propelling the Gene Therapy Market forward?

  • What are the leading companies in the Gene Therapy Industry?

  • What segments does the Gene Therapy Market cover?

  • How can I receive a free copy of the Gene Therapy Market sample report and company profiles?

Report Scope:

Report Attribute

Details

Market Size in 2021

USD 2415.10 Million

Projected Market Size in 2028

USD 7247.58 Million

CAGR Growth Rate

20.10% CAGR

Base Year

2021

Forecast Years

2022-2028

Key Market Players

Novartis AG, Gilead Sciences., Shanghai Sunway Biotech Co. Ltd., Adaptimmune Therapeutics plc., Orchard Therapeutics., Bristol-Myers Squibb., Amgen Inc., Adverum Biotechnologies Inc., Jazz Pharmaceuticals, Shenzhen SiBiono GeneTech, Abeona Therapeutics Inc., Applied Genetic Technologies Corporation, and others

Key Segment

By Vector Type, Therapy, Gene Type, Application, and Region

Major Regions Covered

North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa

Purchase Options

Request customized purchase options to meet your research needs.

Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/gene-therapy-market

(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)

The global gene therapy market is segmented as follows:

By Vector Type

  • Viral Vector

  • Non-Viral Vector

By Therapy

  • In Vivo Therapy

  • Ex Vivo Therapy

By Gene Type

  • Antigen

  • Cytokine

  • Tumor Suppressor

  • Suicide

  • Deficiency

  • Growth factors

  • Receptors

  • Others

By Application

  • Oncological Disorders

  • Rare Diseases

  • Neurological Disorders

  • Other Diseases

By Region

  • North America

    • The U.S.

    • Canada

  • Europe

    • France

    • The UK

    • Spain

    • Germany

    • Italy

    • Rest of Europe

  • Asia Pacific

    • China

    • Japan

    • India

    • Southeast Asia

    • Rest of Southeast Asia

  • The Middle East & Africa

    • GCC

    • South Africa

    • Rest of the Middle East & Africa

  • Latin America

    • Brazil

    • Argentina

    • Rest of Latin America

Request Your Free Sample Report of the Global Gene Therapy Market @ https://www.fnfresearch.com/sample/gene-therapy-market

Key Offerings:

  • Market Size, Trends, & Forecast by Revenue | 2022−2028

  • Market Dynamics – Leading Trends, Growth Drivers, Restraints, and Investment Opportunities

  • Market Segmentation – A detailed analysis by Vector Type, Therapy, Gene Type, Application, and Region

  • Competitive Landscape – Top Key Vendors and Other Prominent Vendors

Browse Other Related Research Reports from Facts & Factors

About Facts & Factors:

Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.

Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.

Follow Us on LinkedIn: https://www.linkedin.com/company/fnfresearch

Follow Us on Twitter: https://twitter.com/fnfresearch

Follow Us on Facebook: https://www.facebook.com/factsandfactors/

Contact Us:

Rushikesh Dorge

USA: +1 347 690-0211

United Kingdom: +44 2032 894158

Japan: +81 50 5806 9039

India: +91 73877 19999

Email: sales@fnfresearch.com

Web: https://www.fnfresearch.com

Blog: http://fnfnewsblog.com